ID   GM12046
AC   CVCL_0V42
AS   CVCL_G459
SY   CEPH-1346-NA12046; 1346-8366
DR   CLO; CLO_0020423
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801105
DR   Coriell; GM12046
DR   dbMHC; 48623
DR   GEO; GSM25546
DR   GEO; GSM25547
DR   GEO; GSM314908
DR   GEO; GSM314909
DR   GEO; GSM420756
DR   GEO; GSM420757
DR   GEO; GSM1719780
DR   IGSR; NA12046
DR   IHW; IHW01089
DR   IPD-IMGT/HLA; 25887
DR   Wikidata; Q54845481
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=29116076;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134614.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:05; B*50:01,57:01; C*06:02,06:02; DPA1*01:03,02:01:01; DPB1*03:01:01,11:01; DQA1*02:01,05:01; DQB1*02:01,02:01; DRB1*03:01,07:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25887).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CAGE-seq analysis.
CC   Omics: CNV analysis.
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 20
//
RX   PubMed=19797678; DOI=10.1101/gr.097600.109;
RA   Nayak R.R., Kearns M., Spielman R.S., Cheung V.G.;
RT   "Coexpression network based on natural variation in human gene
RT   expression reveals gene interactions and functions.";
RL   Genome Res. 19:1953-1962(2009).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=29116076; DOI=10.1038/s41467-017-01467-7;
RA   Garieri M., Delaneau O., Santoni F.A., Fish R.J., Mull D., Carninci P.,
RA   Dermitzakis E.T., Antonarakis S.E., Fort A.;
RT   "The effect of genetic variation on promoter usage and enhancer
RT   activity.";
RL   Nat. Commun. 8:1358.1-1358.9(2017).
//